Advisor Group Holdings, Inc. Immunity Bio, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 103,192 shares of IBRX stock, worth $463,332. This represents 0.0% of its overall portfolio holdings.

Number of Shares

103,192

Previous 74,854 37.86%

Holding current value

$463,332

Previous $473,000 19.24%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.32 - $6.7 $94,082 - $189,864	28,338 Added 37.86%	103,192 $382,000
Q2 2024 Aug 13, 2024	BUY	$4.82 - $9.15 $152,779 - $290,027	31,697 Added 73.45%	74,854 $473,000
Q1 2024 May 10, 2024	BUY	$3.23 - $6.17 $40,727 - $77,797	12,609 Added 41.28%	43,157 $231,000
Q4 2023 Feb 12, 2024	BUY	$1.25 - $5.21 $2,303 - $9,602	1,843 Added 6.42%	30,548 $153,000
Q3 2023 Nov 13, 2023	BUY	$1.29 - $3.1 $20,416 - $49,063	15,827 Added 122.9%	28,705 $48,000
Q2 2023 Aug 10, 2023	SELL	$1.53 - $6.41 $16,271 - $68,170	-10,635 Reduced 45.23%	12,878 $35,000
Q1 2023 May 12, 2023	SELL	$1.35 - $4.78 $3,450 - $12,217	-2,556 Reduced 9.8%	23,513 $42,000
Q4 2022 Feb 10, 2023	SELL	$4.35 - $6.77 $40,076 - $62,372	-9,213 Reduced 26.11%	26,069 $132,000
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $10,084 - $17,766	2,763 Added 8.5%	35,282 $176,000
Q2 2022 Aug 10, 2022	BUY	$2.68 - $6.14 $53,943 - $123,585	20,128 Added 162.44%	32,519 $122,000
Q1 2022 May 04, 2022	SELL	$5.05 - $7.53 $98,121 - $146,307	-19,430 Reduced 61.06%	12,391 $69,000
Q3 2021 Nov 05, 2021	BUY	$9.17 - $14.24 $172,240 - $267,469	18,783 Added 144.06%	31,821 $309,000
Q2 2021 Aug 02, 2021	BUY	$13.41 - $22.4 $117,578 - $196,403	8,768 Added 205.34%	13,038 $186,000
Q1 2021 May 13, 2021	BUY	$12.83 - $42.25 $54,784 - $180,407	4,270 New	4,270 $102,000

Others Institutions Holding IBRX

# of Institutions

202

Shares Held

70M

Call Options Held

1.68M

Put Options Held

1.31M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Immunity Bio, Inc. Transaction History